Latest News and Press Releases

WASHINGTON, Feb. 16, 2023 (GLOBE NEWSWIRE) -- The Cancer Support Community and its social enterprise, Patient Planning Services, are announcing the launch of their newest product Checking IN, the...

BOSTON, July 29, 2022 (GLOBE NEWSWIRE) -- GreenLight Biosciences has announced a collaboration with the National Institutes of Health (NIH) to develop COVID-19 vaccines that are more broadly...

SALT LAKE CITY, Sept. 22, 2021 (GLOBE NEWSWIRE) -- SINTX Technologies, Inc. (www.sintx.com) (NASDAQ: SINT) (“SINTX” or the “Company”), an original equipment manufacturer of advanced ceramics,...

Austin, TX, April 28, 2021 (GLOBE NEWSWIRE) -- QSAM Biosciences Inc. (OTCQB: QSAM), a company developing next-generation nuclear medicines for the treatment of cancer and related diseases, announced...

SAN DIEGO, Sept. 23, 2019 (GLOBE NEWSWIRE) -- Amydis, Inc., a privately-held pharmaceutical company developing proprietary drugs to detect, monitor, and screen for amyloid-related diseases,...

SAN DIEGO, Sept. 26, 2018 (GLOBE NEWSWIRE) -- Amydis, Inc., a privately-held pharmaceutical company developing proprietary chemistry and innovative technology to detect amyloid-related diseases,...

SAN DIEGO, Sept. 26, 2018 (GLOBE NEWSWIRE) -- Amydis, Inc., a privately-held pharmaceutical company developing proprietary chemistry and innovative technology to detect amyloid-related diseases,...

Bethesda, Maryland, Jan. 26, 2018 (GLOBE NEWSWIRE) -- The National Institute of Mental Health (NIMH) Emotion and Development Branch (EDB) is currently seeking a contractor for a...

Bethesda, Maryland, Jan. 03, 2018 (GLOBE NEWSWIRE) -- When we think of government contracts we often think of large organizations undertaking large obligations. On the other hand, sometimes smaller...

SAN DIEGO, Oct. 09, 2017 (GLOBE NEWSWIRE) -- Amydis Diagnostics, Inc., a privately-held pharmaceutical company developing proprietary chemistry and innovative approaches for the detection of...